SUN-LB46 Differences in IGF-I Concentrations Between European and US Populations - Consequences for Reference Intervals

Background: IGF-I is the most widely used biomarker for management of GH related diseases. Reproducible assays and method-specific reference intervals (RIs) are crucial determinants of its clinical utility. Assay validation and RIs based on >15,000 subjects were published for the IDS iSYS IGF-I a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bidlingmaier, Martin, Valcour, Andre, Chun, Kelly Y, Schilbach, Katharina, Kühnle, Tim, Diederich, Sven, Rogge, Thomas, Cavalier, Etienne, Katayev, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Neuroendocrinology and Pituitary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209348/
http://dx.doi.org/10.1210/jendso/bvaa046.2165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209348/
http://dx.doi.org/10.1210/jendso/bvaa046.2165

Ejemplares similares